Indigenous MRNA Vaccine Could Hit Market Before End Of This Year: Gennova

[email protected]02 Nov, 2021News

Pune-based Gennova Biopharmaceuticals has revealed that its mRNA vaccine for COVID-19 is being continuously peer reviewed and is optimistic of launching it before the end of this year. Gennova's HGCO19 is the first mRNA vaccine for COVID-19 being developed in India. NDTV aired a conversation with Sanjay Singh, CEO of Gennova, on Wednesday. Sanjay Singh told NDTV, "Hopefully, if everything goes right, we have successful trial, before the end of the year, we expect [to have] this vaccine in the market."